Results 11 to 20 of about 2,899,588 (264)

Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement

Patient Preference and Adherence, 2018
Pin Gao,1 Lili You,2 Di Wu,1 Aiping Shi,1 Qing Miao,3 Ujala Rana,4 Dustin Paul Martin,3 Ye Du,1 Gang Zhao,1 Bing Han,1 Chao Zheng,5 Zhimin Fan1 1Department of Breast Surgery, First Hospital of Jilin University, Changchun, Jilin, China; 2Department of ...
Gao P, You L, Wu D, Shi A, Miao Q, Rana U, Martin DP, Du Y, Zhao G, Han B, Zheng C, Fan Z   +11 more
doaj   +1 more source

Does patient health literacy impact adherence to adjuvant endocrine therapy in breast cancer patients?

Patient Preference and Adherence, 2018
Jessica Keim-Malpass,1 Aubrey Doede,1 Shayna L Showalter2 1Department of Acute and Specialty Care, University of Virginia School of Nursing, Charlottesville, VA 22908, USA; 2Department of Surgery, University of Virginia School of Medicine ...
Keim-Malpass J, Doede A, Showalter SL
doaj   +1 more source

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy.

, 2022
Immunotherapy treatment with checkpoint inhibitors (CPI) (CTLA-4 and PD-1 inhibitors) significantly improves survival in a number of cancers. Treatment can be limited by immune-mediated adverse effects including endocrinopathies such as hypophysitis ...
Cooksley, T, Higham, CE, Society for Endocrinology Clinical Committee,, Olsson-Brown, A, Morganstein, D, Lorigan, P, Larkin, J, Trainer, PJ, Carroll, P   +8 more
core   +1 more source

A hard pill to swallow: a qualitative study of women’s experiences of adjuvant endocrine therapy for breast cancer [PDF]

, 2014
Objective: To explore women’s experiences of taking adjuvant endocrine therapy as a treatment for breast cancer and how their beliefs about the purpose of the medication, side effects experienced and interactions with health professionals might influence
McCowan, Colin, Harrow, Alison, Thompson, Alastair M., McCowan, C, Radley, Andrew, Wells, Mary, Radley, Andrew; id_orcid, Parsons, Mark, Dryden, R, Dryden, Ruth, Thompson, Alastair M, Parsons, M, Wells, M, Thompson, Alastair, Radley, A, Thompson, AM, Harrow, A   +16 more
core   +1 more source

Endocrine aspects of cancer gene therapy [PDF]

, 2004
The field of cancer gene therapy is in continuous expansion, and technology is quickly moving ahead as far as gene targeting and regulation of gene expression are concerned.
BOSCARO, MARCO, PALU', GIORGIO, BARZON, LUISA   +2 more
core   +1 more source

Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review

, 2022
Endocrine therapy forms the backbone of systemic therapy for the majority of persons with early and late-stage breast cancer. However, the side effects can negatively affect quality of life, and impact treatment adherence and overall oncological outcomes.
Elgene Lim, Lucy R. Haggstrom, Belinda E. Kiely, Emma-Kate Carson, Janette L. Vardy, Davendra Segara   +5 more
core   +1 more source

Lapatinib in the Treatment of Hormone Receptor-Positive/ErbB2-Positive Breast Cancer [PDF]

, 2010
In women with estrogen receptor(ER)- and ErbB2(HER2)-positive breast cancer, a vicious cycle is established between ER mechanisms of action and the growth factor receptor network, leading to enhanced cell proliferation and endocrine resistance.
Bauerfeind, Ingo, Elling, Dirk, Heinemann, Volker   +2 more
core   +1 more source

Notch Signaling Pathway and Endocrine Resistance in Breast Cancer

Frontiers in Pharmacology, 2020
Nearly 70% of breast cancers express the estrogen receptor (ER) and are hormone-dependent for cell proliferation and survival. Anti-estrogen therapies with aromatase inhibitors (AIs), selective estrogen receptor modulators (SERMs) or selective estrogen ...
Jing-Wen Bai, Jing-Wen Bai, Min Wei, Min Wei, Ji-Wei Li, Guo-Jun Zhang, Guo-Jun Zhang   +6 more
doaj   +1 more source

p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer [version 2; peer review: 2 approved]

F1000Research, 2022
Endocrine therapy resistance in Luminal Breast Cancer is a significant issue to be tackled, but currently, no specific biomarker could be used to anticipate this event.
Yohana Azhar, Freda Halim, Bethy Hernowo, Suwarman Suwarman   +3 more
doaj   +1 more source

Adherence to adjuvant therapy in post-menopausal breast cancer patients: A review [PDF]

, 2011
This is the post-print version of the Article. The official published version can be accessed from the link below - Copyright @ 2012 John Wiley & Sons, IncThis review aimed to address the concept of adherence to adjuvant therapy in post-menopausal women.
Banning, M, M. BANNING
core   +1 more source